These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5357133)

  • 1. [Humoral and bacteriological findings in patients with pulmonary tuberculosis during rifampicin therapy].
    Stringa C
    G Ital Mal Torace; 1969; ():Suppl 2:107-8. PubMed ID: 5357133
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial treatment of tuberculosis with streptomycin and isoniazid combined with either aminosalyl or rifampicin.
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Scand J Respir Dis; 1973; 54(2):83-91. PubMed ID: 4122479
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bacteriological relapse among the previously treated advanced pulmonary tuberculosis patients whose sputum converted to negative by the rifampicin treatment, with special reference to the duration of rifampicin administration (author's transl)].
    Yamamoto M; Morishita M; Hirano Y; Nagata A; Yazaki M
    Kekkaku; 1974 Jul; 49(7):195-9. PubMed ID: 4214961
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute renal failure after rifampicin therapy.
    Seufert CD
    Scand J Respir Dis Suppl; 1973; 84():174-9. PubMed ID: 4522073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sputum positive conversion among retreatment cases with pulmonary tuberculosis converted to negative by the use of rifampicin (author's transl)].
    Ito F; Okochi T; Yamazaki M; Yamamoto Y; Kondo K; Konishiike J; Asahi T
    Kekkaku; 1979 Jan; 54(1):37-42. PubMed ID: 107360
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment].
    Yamamoto M; Isoe K; Nakamura H; Hirose H; Izumi S
    Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rifampicin in pulmonary tuberculosis: clinico-radiologic and humoral findings].
    Scarpazza G; Garimoldi M; Cirianni C; Perna G
    G Ital Mal Torace; 1968; 22(5):255-61. PubMed ID: 5704058
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis.
    Joloba ML; Johnson JL; Namale A; Morrissey A; Assegghai AE; Mugerwa RD; Ellner JJ; Eisenach KD
    Int J Tuberc Lung Dis; 2000 Jun; 4(6):528-36. PubMed ID: 10864183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transaminase variation before and during rifampicin treatment of tuberculosis].
    Lévi-Valensi P; Giroulle H; Plaquet R; Dupas JL; Abric J; Danse E; Vonachen P
    Rev Tuberc Pneumol (Paris); 1970; 34(3):422-8. PubMed ID: 5510437
    [No Abstract]   [Full Text] [Related]  

  • 12. Ranitidine--rifampicin interaction.
    Purohit SD; Johri SC; Gupta PR; Mehta YR; Bhatnagar M
    J Assoc Physicians India; 1992 May; 40(5):308-10. PubMed ID: 1483989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results with rifampicin in the treatment of drug-resistant tuberculosis.
    Pines A
    Tubercle; 1969 Mar; 50():Suppl:50-2. PubMed ID: 5402545
    [No Abstract]   [Full Text] [Related]  

  • 14. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
    Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with rifampicin in pulmonary tuberculosis.
    Saeed AH
    Arch Monaldi; 1971; 26(5):433-9. PubMed ID: 5006206
    [No Abstract]   [Full Text] [Related]  

  • 16. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and radiological results of rifampicin therapy in chronic pulmonary tuberculosis].
    Merenda P
    G Ital Mal Torace; 1969; ():Suppl 2:105-6. PubMed ID: 5357132
    [No Abstract]   [Full Text] [Related]  

  • 18. [Rifampicin in therapy of pulmonary tuberculosis verified for the first time: clinico-causistic contribution].
    Ferraro U; Briccarello L; Bonzanino A
    G Ital Mal Torace; 1968; 22(5):287-94. PubMed ID: 5704061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pulmonary tuberculosis with rifampicin].
    Brocard H; Akoun G; Depierre A; Muon N; Tobe FM
    Rev Tuberc Pneumol (Paris); 1969 Mar; 33(2):211-25. PubMed ID: 5385584
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.